Protective Role of Selective Nitric Oxide Synthase Inhibitor for Treatment of Decompensated Hemorrhagic Shock in Normotensive and Hypertensive Rats

Overview

Journal Int J Prev Med

Date 2012 Feb 23

PMID 22355477

Citations 2

Authors

Majid Khazaei

Babak Barmaki

Ali Nasimi

Affiliations

Soon will be listed here.

Abstract

Introduction: Different vasoactive factors can modulate cardiovascular adaptation to hemorrhagic shock including Nitric Oxide (NO). In this study we investigated the effect of the NO synthase inhibitor for treatment of decompensated hemorrhagic shock in normotensive and hypertensive rats.

Methods: Twenty-four male Wistar rats were divided into two groups: The normotensive and hypertensive groups. Hypertension was induced by the DOCA-Salt method for eight weeks. Then, the animals were given hemorrhagic shock by continuously withdrawing blood until the mean arterial pressure (MAP) reached to 40 mmHg. The animals were maintained in the shock state for 120 minutes. Subsequently, they were randomly assigned to L-NAME-treated and non-treated groups and monitored for 60 minutes. The survival time was recorded. Blood samples were taken before and after the shock and 60 minutes after L-NAME administration.

Results: Infusion of L-NAME caused a significant increase in MAP in normotensive animals, however, slightly increased MAP in hypertensive animals. The heart rate did not significantly alter. Hemorrhage caused a marked increase in serum nitrite levels in both groups (P<0.05). L-NAME treatment significantly reduced the serum nitrite concentration in the normotensive group (P<0.05), without any change in the hypertensive group. All animals who received L-NAME treatment survived at the end of experiment. Fifty percent of the hypertensive animals died four hours after the experiment. The 72-hour survival rate was similar in the L-NAME treated groups.

Conclusion: L-NAME infusion during decompensated hemorrhagic shock plays a protective role in the improvement of hemodynamic responses and short-term survival rate in normotensive animals.

Citing Articles

Preclinical studies of NOS inhibitor T1059 vasopressor activity on the models of acute hemorrhagic shock in rats and dogs.

Filimonova M, Shevchenko L, Makarchuk V, Saburova A, Shegay P, Kaprin A Front Pharmacol. 2022; 13:995272.

PMID: 36249787 PMC: 9561252. DOI: 10.3389/fphar.2022.995272.

Defensive effect of natrium diethyldithiocarbamate trihydrate (NDDCT) and lisinopril in DOCA-salt hypertension-induced vascular dementia in rats.

Sharma B, Singh N Psychopharmacology (Berl). 2012; 223(3):307-17.

PMID: 22526544 DOI: 10.1007/s00213-012-2718-9.

References

Sinert R, Guerrero P, Quintana E, Zehtabchi S, Kim C, Agbemadzo A . The effect of hypertension on the response to blood loss in a rodent model. Acad Emerg Med. 2000; 7(4):318-26. DOI: 10.1111/j.1553-2712.2000.tb02229.x. View

Liu L, Ward J, Dubick M . Hemorrhage-induced vascular hyporeactivity to norepinephrine in select vasculatures of rats and the roles of nitric oxide and endothelin. Shock. 2003; 19(3):208-14. DOI: 10.1097/00024382-200303000-00003. View

Cabrales P, Tsai A, Intaglietta M . Exogenous nitric oxide induces protection during hemorrhagic shock. Resuscitation. 2009; 80(6):707-12. PMC: 2747810. DOI: 10.1016/j.resuscitation.2009.03.001. View

Schmetterer L, Dallinger S, Polak K, Eichler H, Wolzt M . Systemic NO synthase inhibition blunts the chronotropic, but not the inotropic response to isoprenaline in man. Nitric Oxide. 1999; 3(3):209-15. DOI: 10.1006/niox.1999.0223. View

Beswick R, Zhang H, Marable D, Catravas J, Hill W, Webb R . Long-term antioxidant administration attenuates mineralocorticoid hypertension and renal inflammatory response. Hypertension. 2001; 37(2 Pt 2):781-6. DOI: 10.1161/01.hyp.37.2.781. View

Jiang M, Kaku T, Hada J, Hayashi Y . Different effects of eNOS and nNOS inhibition on transient forebrain ischemia. Brain Res. 2002; 946(1):139-47. DOI: 10.1016/s0006-8993(02)02870-6. View

Ajayi AAL , Hercule H, Pamugo J, Dixon D, Oyekan A . Interactions of the renin-angiotensin system and alpha-1 adrenoceptors on renal hemodynamics in healthy and acute renal failure rats: the role of nitric oxide. Blood Press. 2002; 10(4):238-46. DOI: 10.1080/08037050152669765. View

Forstermann U . Nitric oxide and oxidative stress in vascular disease. Pflugers Arch. 2010; 459(6):923-39. DOI: 10.1007/s00424-010-0808-2. View

Lange M, Enkhbaatar P, Nakano Y, Traber D . Role of nitric oxide in shock: the large animal perspective. Front Biosci (Landmark Ed). 2009; 14(5):1979-89. DOI: 10.2741/3357. View

10.

Schadt J, Ludbrook J . Hemodynamic and neurohumoral responses to acute hypovolemia in conscious mammals. Am J Physiol. 1991; 260(2 Pt 2):H305-18. DOI: 10.1152/ajpheart.1991.260.2.H305. View

11.

Dutton R . Current concepts in hemorrhagic shock. Anesthesiol Clin. 2007; 25(1):23-34, viii. DOI: 10.1016/j.atc.2006.11.007. View

12.

Liu L, Dubick M . Hemorrhagic shock-induced vascular hyporeactivity in the rat: relationship to gene expression of nitric oxide synthase, endothelin-1, and select cytokines in corresponding organs. J Surg Res. 2005; 125(2):128-36. DOI: 10.1016/j.jss.2004.12.008. View

13.

Radisavljevic Z . Hypertension-induced dysfunction of circulation in hemorrhagic shock. Am J Hypertens. 1995; 8(7):761-7. DOI: 10.1016/0895-7061(95)00075-Z. View

14.

Balaszczuk A, Arreche N, Mc Laughlin M, Arranz C, Fellet A . Nitric oxide synthases are involved in the modulation of cardiovascular adaptation in hemorrhaged rats. Vascul Pharmacol. 2006; 44(6):417-26. DOI: 10.1016/j.vph.2006.02.008. View

15.

Nematbakhsh M, Khazaei M . The effect of estrogen on serum nitric oxide concentrations in normotensive and DOCA Salt hypertensive ovariectomized rats. Clin Chim Acta. 2004; 344(1-2):53-7. DOI: 10.1016/j.cccn.2004.01.019. View

16.

Sinert R, Spencer M, Wilson R, Silverberg M, Patel M, Doty C . The effect of hypertension on uncontrolled hemorrhage in a rodent model. Acad Emerg Med. 2002; 9(8):767-74. DOI: 10.1111/j.1553-2712.2002.tb02162.x. View

17.

Gkaliagkousi E, Douma S, Zamboulis C, Ferro A . Nitric oxide dysfunction in vascular endothelium and platelets: role in essential hypertension. J Hypertens. 2009; 27(12):2310-20. DOI: 10.1097/HJH.0b013e328330e89a. View

18.

Ng K, Moochhala S, Md S, Yap E, Low S, Lu J . Preservation of neurological functions by nitric oxide synthase inhibitors following hemorrhagic shock. Neuropharmacology. 2003; 44(2):244-52. DOI: 10.1016/s0028-3908(02)00368-4. View

19.

Sato S, Suzuki A, Nakajima Y, Iwamoto T, Bito H, Miyabe M . S-Nitroso-N-acetylpenicillamine (SNAP) during hemorrhagic shock improves mortality as a result of recovery from vascular hyporeactivity. Anesth Analg. 2000; 90(2):362-8. DOI: 10.1097/00000539-200002000-00023. View

20.

Koch M, Hasser E, Schadt J . Influence of nitric oxide on the hemodynamic response to hemorrhage in conscious rabbits. Am J Physiol. 1995; 268(1 Pt 2):R171-82. DOI: 10.1152/ajpregu.1995.268.1.R171. View